Cost utility of the latest antipsychotics in severe schizophrenia (CUtLASS): a multi-centre, randomised, controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN33419176

Enrollment

227

Registered

2003-04-25

Start date

1999-05-01

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and behavioural disorders: Schizophrenia and other psychoses Mental and Behavioural Disorders Schizophrenia

Interventions

Please note that, as of 14 January 2008, the anticipated start and end dates of this trial have been updated from 1 March 1999 and 28 February 2002 to 1 May 1999 and 30 June 2003, respectively.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Schizophrenics who are intolerant or resistant to usual treatment

Exclusion criteria

Exclusion criteria: 1. Substance use or organic illness as the main cause of psychotic symptoms. 2. History of neuroleptic malignant syndrome (NMS)

Design outcomes

Primary

Measure	Time frame
Quality of life	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026